Perinatal And Postpartum Mood Disorders

"As a psychotherapist and educator of future mental health practitioners, I believe this work fills an important gap in reference books for professionals who care for childbearing women. Since the volume provides invaluable neurobiological research on depression and anxiety, I recommend this work to all health and mental health professionals."--Illness, Crisis and Loss Over the past three years, pregnancy related mood disorders have become the focus of health care advocates and legislators alike with subsequent reflection in nationwide media. Statistics on the prevalence of perinatal mood disorders suggest that up to 20% of women experience diagnosable pregnancy related mood disorders. The growing recognition of these common disorders, coupled with an increasing knowledge base about the dire consequences of untreated maternal depression, has propelled this issue to the fore of national public health priorities. This increasing awareness has also resulted in recent legislative and healthcare initiatives to screen, assess, and treat such disorders. On April 13, 2006, Governor Jon S. Corzine (D -NJ) signed a law requiring all new mothers to be educated and screened for postpartum depression. This law is the first of its kind in the country, but many states and federal advocates are proposing similar laws. The motivation for states and the federal government to adopt education and screening program is high and may soon be a federal mandate. But a major barrier to successful implementation of such programs is the lack of available resources to train healthcare professionals in this specialty. This book offers a major resource for healthcare professionals, mental health professionals, and medical, nursing, psychology, and social work students who will be confronting this problem in their practices. The contributions, by renowned experts, fill a glaring gap in the knowledge professionals need in order to successfully manage maternal mental health.

This text provides background on the history of perinatal psychiatry, and discusses future directions in the field. It clearly defines perinatal mood and anxiety disorders (PMADs), which are the most common complication of pregnancy. When left untreated, PMADs are morbid and devastating for both the patient and their entire family. It reviews gold standard recommendations for the treatment of PMADs, including evidence-based psychotherapies, as well as risk-benefit analysis of psychotropic medication use in pregnancy and lactation. Additionally, common presentations of depression, anxiety, and trauma in pregnancy and postpartum women, as well as mania, psychosis, suicidal and homicidal thoughts are reviewed. Women’s Mood Disorders: A Clinician’s Guide to Perinatal Psychiatry highlights special considerations in pregnancy, including teenage pregnancies, hyperemesis gravidum, eating disorders, substance abuse disorders, as well as infertility, miscarriage and loss. The text concludes with outlining the importance of collaborative care in providing gold standard treatment of perinatal women and review documentation and legal considerations. This handbook will help educate and train future psychiatrists and OBGYNs in feeling confident and comfortable assessing and treating pregnant women who suffer from PMADs.

Biomarkers of Postpartum Psychiatric Disorders provides an up-to-date reference on the current research relating to biomarkers in psychiatric disorders, including major depressive disorder, OCD and bipolar disorder in the immediate postpartum time-period. It is the only reference on the market that synthesizes and interprets available data and reviews clinical phenotypes. Topics cover hormonal contributions, immunology, epigenetics and neuroimaging. While the risk of psychiatric illness during pregnancy appears to be equivalent to the risk at any other time in a woman’s life, the risk in the immediate postpartum time period is dramatically increased, hence the importance of the discussions in this title. Identifies epigenetic, hormonal, immunological and neuroimaging biomarkers Provides biomarkers for depression, OCD and psychosis Includes clinical phenotypes for psychiatric disorders Discusses future research and directions in the field

This 2019 edition of Beyond the Blues contains the most current pregnancy and postpartum resources for prevention and treatment of mental health challenges for all parents. Updated information and research about medications, as well as complementary and alternative options are included. Direct and compassionate, it is required reading for those suffering before or after the baby is born and for all professionals working with them. “An indispensable guide to understanding and treating prenatal and postpartum depression. This book is a gift not only to healthcare providers but also to family and friends of mothers suffering from these devastating perinatal mood disorders.” —Cheryl Tatano Beck, DNSc, CNM, FAAN Professor, University of Connecticut, School of Nursing Coauthor of Postpartum Depression Screening Scale “In Beyond the Blues, Bennett and Indman offer a compact yet surprisingly comprehensive manual on prenatal and postpartum depression. Readable and practical, they systematically address screening and assessment, finding a therapist, myths about nursing and bonding, and treatment. Interesting and helpful are suggestions for family and friends. For health professionals, there is detailed diagnostic and treatment information. Beyond the Blues is a quick read with an easy-to-handle format. Recommended for consumer health and health sciences collections.” —Library Journal “This book will be of great help for both women and their health care providers, providing information on all aspects of depression in pregnancy and in the post-postpartum, including safety/risk of medication therapy.” —Adrienne Einarson RN Assistant Director, The Motherisk Program, The Hospital for Sick Children, Toronto, Canada “Take prenatal vitamins for the baby, but for the long-term health of the mother, this is a must read for both her and her doctor.” —Timothy A. Leach, M.D., F.A.C.O.G. OB/GYN, San Ramon Regional Medical Center, John Muir Medical Center

Designed for clinicians delivering postpartum care, including clinicians, midwives, OB-GYN nurse practitioners, and women's health practitioners, this text overviews the six different mood and anxiety disorders that may present during a woman's postpartum year. Postpartum Mood and Anxiety Disorders focuses on assessment, screening tools, diagnosis, treatment, and implications for practice, and includes case studies to integrate the process.

This comprehensive reference and text synthesizes a vast body of clinically useful knowledge about women's mental health and health care. Coverage includes women's psychobiology across the life span--sex differences in neurobiology and psychopharmacology and psychiatric aspects of the reproductive cycle--as well as gender-related issues in assessment and treatment of frequently encountered psychiatric disorders. Current findings are presented on sex differences in epidemiology, risk factors, presenting symptoms, treatment options and outcomes, and more. Also addressed are mental health consultation to other medical specialties, developmental and sociocultural considerations in service delivery, and research methodology and health policy concerns.

Postpartum depression affects 10-15 percent of women any time from a month to a year after childbirth. Women with postpartum depression may feel restless, anxious, sad or depressed. They may have feelings of guilt, decreased energy and motivation, and a sense of worthlessness. They may also have sleep difficulties and undergo unexplained weight loss or gain. Some mothers may worry about hurting themselves or their baby. In extremely rare cases - less than 1 percent of new mothers - women may develop something called postpartum psychosis. It usually occurs within the first few weeks after delivery. Symptoms may include refusing to eat, frantic energy, sleep disturbance, paranoia and irrational thoughts. Women with postpartum psychosis usually need to be hospitalised.

Mood and Anxiety Disorders During Pregnancy and Postpartum earns its important place in the literature by detailing our current understanding of the course, diagnosis, and treatment of psychiatric illness during pregnancy and postpartum, including breast-feeding -- a top priority today because we now know that active maternal psychiatric illness during pregnancy and postpartum can exert long-term negative effects on child development and cause significant morbidity for the mother. In just five concise richly informative chapters, the nine distinguished contributors to Mood and Anxiety Disorders During Pregnancy and Postpartum dispel prevailing beliefs and offer invaluable guidance in treating women during pregnancy and postpartum: Course of Psychiatric Illness During Pregnancy and the Postpartum Period -- Despite the enduring belief that pregnancy is a time of emotional well-being for women, emerging data show that pregnancy is instead a time of increased vulnerability to psychiatric illness. Diagnosis and Treatment of Mood and Anxiety Disorders During Pregnancy -- Though the use of psychotropic medications during pregnancy and postpartum raises concerns, the accumulating data support the use of certain SSRIs/tricyclic antidepressants, especially when balanced against the risk to both mother and child of depression during pregnancy. Management of Bipolar Disorder During Pregnancy and the Postpartum Period: Weighing the Risks and Benefits -- Although the onset of bipolar disorder (BP) tends to occur during women's reproductive years, surprisingly little is known about the impact of the menstrual cycle, pregnancy, postpartum, breast-feeding, and menopause on the course and treatment of bipolar disorder. Postpartum Mood Disorders -- Women experience a dramatic increase in their risk of developing severe psychiatric illness during postpartum for a full year after delivery. Often overlooked, postpartum disorders must be identified and treated as early as possible to reduce the mother's risk for recurrent and treatment-refractory illness and the child's risk for long-term development problems due to the detrimental effect of maternal depression. Use of Antidepressants and Mood Stabilizers in Breast-feeding Women -- This expanded clinical appraisal of the literature on antidepressant and mood stabilizer use in breast-feeding women shows that additional detailed pharmacokinetic investigations are urgently needed to enhance our understanding of nursing infant exposure and the role(s) of pharmacogenomics in determining infant exposure. Meticulously referenced and remarkably succinct, Mood and Anxiety Disorders During Pregnancy and Postpartum provides critical information about the course of illness during pregnancy and postpartum to help guide effective individualized treatment decisions-decisions that are ultimately based on the patient's wishes.